Humanigen Inc (fka HGENQ)

[cowtown jay]

Gilead's Magrolimab strikes out as blood cancer treatment.

I think we will once again see the ultra value lenz has to enhance the efficacy of the primary treatment therapeutic, in this case, azacitidine, which is being used in our trial as well.

https://www.reuters.com/business/healthcare-pharmaceuticals/gilead-stops-late-stage-trial-blood-cancer-treatment-2023-07-21/#:~:text=July%2021%20(Reuters)%20%2D%20Gilead,it%20would%20not%20be%20effective.